RS

Ravindra Salecha

Director Director DIN 01498983
DIN 01498983 First appointment Jun 2003 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2003
Shareholding value •••• Premium profile

About Ravindra Salecha

Data last updated:

Ravindra Salecha was a Director at Neelkanth Health Care Private Limited (2003–2021) and Designated Partner at Neelkanth Finechem Llp (2016–2022). The companies operate in Healthcare and Chemicals and Materials.

DIN 01498983
Primary Designation Director
Industry Healthcare
First Appointment 25 Jun 2003

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jun 20032003₹7.14 Cr (FY 2025)Active
Designated Partner14 Jun 20162016₹17.44 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neelkanth Health Care Private Limited
Neelkanth Finechem Llp
Premium access

Shareholding and investment profile for Ravindra Salecha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Salecha

Ravindra Salecha was first appointed on 25 Jun 2003 as Director at Neelkanth Health Care Private Limited. The most recent appointment on record is 14 Jun 2016 at Neelkanth Finechem Llp.

Ravindra Salecha held 2 earlier board appointments: Neelkanth Health Care Private Limited (Director, 25 Jun 2003 to 30 Dec 2021); Neelkanth Finechem Llp (Designated Partner, 14 Jun 2016 to 21 Jan 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available